Skip to content

PHARMA-BIO SERV, INC.: 10-Q filed 2012-06-14

What PHARMA-BIO SERV, INC. reported in its quarterly report filed 2012-06-14 (fiscal Q2 2012): 31 published measures, 104 facts as tagged in accession 0001354488-12-003234.

This filing

Form
10-Q (quarterly report)
Filed
2012-06-14
Fiscal period
fiscal Q2 2012
Accession
0001354488-12-003234 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHARMA-BIO SERV, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-04-3012,512,461USD
At 2011-10-3110,852,199USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-04-301,978,935USD
At 2011-10-312,615,874USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-04-3010,533,526USD
At 2011-10-318,236,325USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-04-303,975,522USD
At 2012-01-314,168,789USD
At 2011-10-314,316,725USD
At 2011-04-302,552,989USD
At 2011-01-312,406,980USD
At 2010-10-312,317,168USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-02-01 to 2012-04-301,188,009USD90
2011-11-01 to 2012-04-302,334,543USD182
2011-02-01 to 2011-04-30479,692USD89
2010-11-01 to 2011-04-30835,952USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-02-01 to 2012-04-30-99,711USD90
2011-11-01 to 2012-04-30-205,752USD182
2011-02-01 to 2011-04-30187,027USD89
2010-11-01 to 2011-04-30293,145USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-02-01 to 2012-04-3088,878USD90
2011-11-01 to 2012-04-3095,839USD182
2011-02-01 to 2011-04-3056,150USD89
2010-11-01 to 2011-04-3066,215USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-02-01 to 2012-04-30-7,701USD90
2011-11-01 to 2012-04-30-15,238USD182
2011-02-01 to 2011-04-30-5,391USD89
2010-11-01 to 2011-04-30-9,815USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-02-01 to 2012-04-30-88,878USD90
2011-11-01 to 2012-04-30-95,158USD182
2011-02-01 to 2011-04-30-56,150USD89
2010-11-01 to 2011-04-30-66,215USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-04-309,934,251USD
At 2011-10-317,599,708USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-02-01 to 2012-04-3020,758,695shares90
2011-11-01 to 2012-04-3020,758,695shares182
2011-02-01 to 2011-04-3020,751,215shares89
2010-11-01 to 2011-04-3020,751,215shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-02-01 to 2012-04-3022,829,079shares90
2011-11-01 to 2012-04-3022,802,937shares182
2011-02-01 to 2011-04-3022,483,430shares89
2010-11-01 to 2011-04-3022,479,368shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-02-01 to 2012-04-300.057USD/shares90
2011-11-01 to 2012-04-300.112USD/shares182
2011-02-01 to 2011-04-300.023USD/shares89
2010-11-01 to 2011-04-300.04USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-02-01 to 2012-04-300.052USD/shares90
2011-11-01 to 2012-04-300.102USD/shares182
2011-02-01 to 2011-04-300.021USD/shares89
2010-11-01 to 2011-04-300.037USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-02-01 to 2012-04-30237,920USD90
2011-11-01 to 2012-04-30455,058USD182
2011-02-01 to 2011-04-30259,426USD89
2010-11-01 to 2011-04-30424,108USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-04-301,159,275USD
At 2011-10-311,216,111USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-02-01 to 2012-04-3017,166USD90
2011-11-01 to 2012-04-3019,332USD182
2011-02-01 to 2011-04-302,166USD89
2010-11-01 to 2011-04-304,332USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-02-01 to 2012-04-301,425,813USD90
2011-11-01 to 2012-04-302,787,758USD182
2011-02-01 to 2011-04-30736,755USD89
2010-11-01 to 2011-04-301,254,282USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-04-3011,324,294USD
At 2011-10-319,607,782USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-02-01 to 2012-04-302,081USD90
2011-11-01 to 2012-04-304,328USD182
2011-02-01 to 2011-04-301,991USD89
2010-11-01 to 2011-04-303,341USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-04-301,903,277USD
At 2011-10-312,523,637USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-04-306,944,808USD
At 2011-10-314,864,616USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-02-01 to 2012-04-302,396,143USD90
2011-11-01 to 2012-04-304,642,788USD182
2011-02-01 to 2011-04-301,545,000USD89
2010-11-01 to 2011-04-302,721,008USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-02-01 to 2012-04-30970,330USD90
2011-11-01 to 2012-04-301,855,030USD182
2011-02-01 to 2011-04-30808,245USD89
2010-11-01 to 2011-04-301,466,726USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-04-3020,758,695shares
At 2011-10-3120,758,695shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-04-30-76,683USD
At 2011-10-31-20,009USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-04-3028,892USD
At 2011-10-3128,306USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-02-01 to 2012-04-301,425,929USD90
2011-11-01 to 2012-04-302,789,601USD182
2011-02-01 to 2011-04-30739,118USD89
2010-11-01 to 2011-04-301,260,060USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-02-01 to 2012-04-3075,408USD90
2011-11-01 to 2012-04-30151,701USD182
2011-02-01 to 2011-04-3074,128USD89
2010-11-01 to 2011-04-30148,841USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-02-01 to 2012-04-30116USD90
2011-11-01 to 2012-04-301,843USD182
2011-02-01 to 2011-04-302,363USD89
2010-11-01 to 2011-04-305,778USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-02-01 to 2012-04-30-1,193,427USD90
2011-11-01 to 2012-04-30-2,122,938USD182
2011-02-01 to 2011-04-30-812,507USD89
2010-11-01 to 2011-04-30-1,420,966USD181

Inspect the source

Entity
PHARMA-BIO SERV, INC. / CIK 0001304161
Captured
2026-09-19T11:17:27.241Z
SEC response SHA-256
bc9f33e072a9daa74aa0e8c41fbfef83d107920bc25647db80386f28787f2d49

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001304161.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))